SCHEMBL10041774

SCHEMBL10041774

CN(C)NO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12347314 0.74
SCHEMBL12686655 0.67
SCHEMBL14565892 0.65 KDM7A (0.32)
SCHEMBL170103 0.59
SCHEMBL28644621 0.59
SCHEMBL1796257 0.59
SCHEMBL15241371 0.59
Dimethylamine SCHEMBL25282910 0.56
SCHEMBL8370833 0.56
SCHEMBL3794951 0.56

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3383874-A1 MESOIONIC HALOGENATED 3-(ACETYL)-1-[(1,3-THIAZOL-5-YL)METHYL]-1H-IMIDAZO[1,2-A]PYRIDIN-4-IUM-2-OLATE DERIVATIVES AND RELATED COMPOUNDS AS INSECTICIDES Bayer CropScience Aktiengesellschaft (DE) 2018-10-10 EP disclosed
CN-108130801-A The method that production is used for the activation colloidal silicon dioxide of papermaking 艺康美国股份有限公司 2018-06-08 CN disclosed
WO-2017093214-A1 MESOIONIC HALOGENATED 3-(ACETYL)-1-[(1,3-THIAZOL-5-YL)METHYL]-1H-IMIDAZO[1,2-A]PYRIDIN-4-IUM-2-OLATE DERIVATIVES AND RELATED COMPOUNDS AS INSECTICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-06-08 WO disclosed
EP-2957559-A1 Iminosydnone derivatives for conjugation and release of compounds of interest L'Universite de Strasbourg (FR) 2015-12-23 EP disclosed
US-8257707-B2 IL-18 receptor antigen binding proteins AMGEN INC. (US) 2012-09-04 US disclosed
WO-2012048171-A9 VARIANT CBH I POLYPEPTIDES WITH REDUCED PRODUCT INHIBITION BP CORPORATION NORTH AMERICA INC. (US) 2012-08-30 WO disclosed
US-8168063-B2 Dialysis system having filtering method for determining therapy prescriptions BAXTER INTERNATIONAL INC. (US) 2012-05-01 US disclosed
US-20110018657-A1 Substrate Integrated Waveguide CHENG SHI 2011-01-27 US disclosed
US-20110014201-A1 IL-18 RECEPTOR ANTIGEN BINDING PROTEINS AMGEN INC. (US) 2011-01-20 US disclosed
US-20100010423-A1 DIALYSIS SYSTEM HAVING FILTERING METHOD FOR DETERMINING THERAPY PRESCRIPTIONS BAXTER INTERNATIONAL INC. (US) 2010-01-14 US disclosed
US-20090197323-A1 Identification and characterization of a novel alpha-amylase from maize endosperm IOWA STATE UNIVERSITY RESEARCH FOUDATION, INC. (US) 2009-08-06 US disclosed
US-20070060603-A1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds PFIZER INC. 2007-03-15 US disclosed